Abstract
Methylenetetrahydrofolate reductase (MTHFR) is key enzyme of folate/homocysteine pathway. Case control association studies on MTHFR C677T polymorphism and Alzheimer’s disease (AD) have been repeatedly performed over the last two decades, but the results are inconclusive. The aim of the present study was to assess the risk of MTHFR C677T polymorphism for AD. Forty-one studies were identified by a search of PubMed, Google Scholar, Elsevier, and Springer Link databases, up to January 2015. Odds ratios (ORs) with corresponding 95 % confidence interval (CI) were calculated using fixed effect model or random effect model. The subgroup analyses based on ethnicity were performed. MTHFR C677T polymorphism had a significant association with susceptibility to AD in all genetic models (for T vs C OR = 1.29, 95 % CI = 1.07–1.56, p = 0.003; for TT + CT vs CC OR = 1.29, 95 % CI = 1.19–1.40, p = 0.0004; for TT vs CC OR = 1.31, 95 % CI = 1.16–1.48, p = 0.001; for CT vs CC OR = 1.24, 95 % CI = 1.13–1.35, p < 0.004; and for TT vs CT + CC OR = 1.13, 95 % CI = 1.00–1.28, p = 0.02). Results of present meta-analysis supported that the MTHFR C677T polymorphism was associated with an increased risk of AD.
Similar content being viewed by others
References
Luchsinger J, Mayeux R (2004) Cardiovascular risk factors and Alzheimer’s diseases. Curr Atheroscler Rep 6:261–266
Wingo TS, Lah JJ, Levey AI, Cutler DJ (2012) Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol 69:59–64
Prince DL, Sisodia SS, Borchett DR (1998) Alzheimer disease: when or why? Nat Genet 19:314–316
Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, Levesque G, Rogaev EI et al (1996) Fifteen-year longitudinal study of blood pressure and dementia. Lancet 347:1141–1145
Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346:476–483
Ott A, Stolk RP, van Harskamp F et al (1999) Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology 53:1937–1942
Jick H, Zornberg GL, Jick SS et al (2000) Statins and the risk of dementia. Lancet 356:1627–1631
Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80:114–122
Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr 130:129–132
Yadav U, Kumar P, Yadav SK, Mishra OP, Rai V (2015) Polymorphisms in folate metabolism genes as maternal risk factor for neural tube defects: an updated meta-analysis. Metab Brain Dis 9:25005003
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113
Yamada K, Zhoutao C, Rima R, Mathews RG (2001) Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proc Natl Acad Sci U S A 98:14853–14858
Rozen R (1997) Genetic predisposition to hyperhomocysteinemia: deficiency of methelenetetrahydrofolate reductase (MTHFR). Thromb Haemost 78:523–526
Pepe G, Venegas OC, Giusti B, Brunelli T, Marcucci R, Attanasio M et al (1998) Heterogeneity in world distribution of thermolabile C677T mutation in 5, 10-methylenetetrahydrofolate reductase. Am J Hum Genet 63:917–920
Schneider JA, Rees DC, Liu YT, Clegg JB (1998) World distribution of a common methylenetetrahydrofalate reductase mutation. Am J Hum Gene 62:1258–1260
Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, Renlund M et al (2003) Geographical and ethnic variation of the 677C > T allele of 5,10-methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas worldwide. J Med Genet 40:619–625
Spiridonova MG, Stepanov VA, Maksimova NR, Puzyrev VP (2004) Population study of frequency of methylenetetrahydrofolate reductase C677T gene polymorphism in Yakutia. Genetika 40:704–708
Rai V, Yadav U, Kumar P (2012) Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh. Indian J Human Genetics 18:43–46
Kluijtmans LA, Young IS, Boreham CA, Murray L, McMaster D, McNulty H et al (2003) Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 101:2483–2488
Devlin AM, Clarke R, Birks J, Evans JG, Halsted CH (2006) Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am J Clin Nutr 83:708–713
Chapman J, Wang N, Treves A, Korczyn AD, Bornstein NM (1998) ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer’s dementia. Stroke 29:1401–1404
Brunelli T, Bagnoli S, Giusti B, Nacmias B, Pepe G, Sorbi S, Abbate R (2001) The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer’s disease. Neurosci Lett 315:103–105
Zuliani G, Ble A, Zanca R, Munari MR, Zurlo A, Vavalle C, Atti AR, Fellin R (2001) Genetic polymorphisms in older subjects with vascular or Alzheimer’s dementia. Acta Neurol Scand 103:304–308
Religa D, Styczynska M, Peplonska B, Gabryelewicz T, Pfeffer A, Chodakowska M, Luczywek E, Wasiak B et al (2003) Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer’s disease and mild cognitive impairment. Dement Geriatr Cogn Disord 16:64–70
Seripa D, Forno GD, Matera MG, Gravina C, Margaglione M, Palermo MT, Wekstein DR, Antuono P et al (2003) Methylenetetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohort of Alzheimer patients. Neurobiol Aging 24:933–939
Linnebank M, Linnebank A, Jeub M, Klockgether T, Wullne U, Kolsch H, Heun R, Koch HG et al (2004) Lack of genetic dispositions to hyperhomocysteinemia in Alzheimer disease. Am J Med Genet A 131:101–102
Wang B, Jin F, Kan R, Ji S, Zhang C, Lu Z, Zheng C, Yang Z et al (2005) Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer’s disease. J Mol Neurosci 27:23–27
Pandey P, Pradhan S, Modi DR, Mittal B (2009) MTHFR and ACE gene polymorphisms and risk of vascular and degenerative dementias in the elderly. Brain Cogn 71:295–299
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008–2012
Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101–129
Higgins JP, Thompson SE (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
Whitehead A (2002) Meta-analysis of controlled clinical trials. John Wiley & Sons Ltd, Chichester, West Sussex, England
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
Egger M, Dave Smith G, Schneider M, Minde C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Bax L, Yu ILM, Tsuruta N, Moons KG (2006) Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 6:50
Nishiyama M, Kato Y, Hashimoto M, Yukawa S, Omori K (2000) Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia—an epidemiological study using the polymerase chain reaction (PCR) method. J Epidemiol 10:163–172
Pollak RD, Pollak A, Idelson M, Bejarano-Achache I, Doron D, Blumenfeld A (2000) The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J Am Geriatr Soc 48:664–668
Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G (2001) Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer’s dementia. A case-control study. Gerontology 47(6):324–329
McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP (2002) Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke 33:2351–2356
Wakutani Y, Kowa H, Kusumi M, Yamagata K, Wada-Isoe K, Adachi Y, Takeshima T, Urakam K et al (2002) Genetic analysis of vascular factors in Alzheimer’s disease. Ann N Y Acad Sci 977:232–238
Anello G, Gueant-Rodriguez RM, Bosco P, Gueant JL, Romano A, Namour B, Spada R, Caraci F et al (2004) Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer’s disease. Neuroreport 15:859–861
Bi S, Pan S, Zhang Y, Wu J (2004) Relationship between folate £-vitamin B12 plasma homocysteine levels and polymorphism of MTHFR gene in Alzheimer’s disease. Chin J Mod Med 977:15–18
Jiang K, Li F, Zhang M, Qian Y, Wang D, Zhang Y, Jiang S (2004) A study on relationship between the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and Alzheimer disease. Shanghai Arch Psyc 16:196–208
Kida T, Kamino K, Yamamoto M, Kanayama D, Tanaka T, Kudo T, Takeda M (2004) C677T polymorphism of methylenetetrahydrofolate reductase gene affects plasma homocysteine level and is a genetic factor of late-onset Alzheimer’s disease. Psychogeriatrics 4:4–10
Liao W, Huang S, Chen S, Wang Y, Liu X (2004) The relationship of polymorphism of MTHFR and plasma homocysteine level with Alzheimer’s disease. Zhong Guo You Sheng Yi Yi Chuan 12:13–15
Wang L, Ye L, Wu D, Liu J, Niu J (2004) Genetic risk factors of sporadic Alzheimer’s disease among Chinese in Beijing. Chin J Geriatr 23:460–463
Fernandez LL, Scheibe RM (2005) Is MTHFR polymorphism a risk factor for Alzheimer disease like APOE? Arq Neuropsiquiatr 63:1–6
Zhang YD, Ke XY, Shen W, Liu Y (2005) Relationship of homocysteine and gene polymorphisms of its related metabolic enzymes with Alzheimer’s disease. Chin Med Sci J 20:247–251
da Silva VC, Ramos FJ, Freitas EM, de Brito-Marques PR, Cavalcanti MN, D’Almeida V, Cabral-Filho JE, Muniz MT (2006) Alzheimer’s disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms. Arq Neuropsiquiatr 64:941–945
Keikhaee MR, Hashemi SB, Najmabadi H, Noroozian M (2006) C677T methylentetrahydrofolate reductase and angiotensin converting enzyme gene polymorphisms in patients with Alzheimer’s disease in Iranian population. Neurochem Res 31:1079–1083
Wehr H, Bednarska-Makaruk M, Łojkowska W, Graban A, Hoffman-Zacharska D, Kuczynska-Zardzewiały A, Mrugała J, Rodo M et al (2006) Differences in risk factors for dementia with neurodegenerative traits and for vascular dementia. Dement. Geriatr Cogn Disord 22:1–7
Dorszewska J, Florczak J, Rozycka A, Kempisty B, Jaroszewska-Kolecka J, Chojnacka K, Trzeciak WH, Kozubski W (2007) Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer’s and Parkinson’s diseases. Acta Neurobiol Exp (Wars) 67:113–129
Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Shin HY, Yoon JS (2008) Methylenetetrahydrofolate reductase gene and risk of Alzheimer’s disease in Koreans. Int J Geriatr Psychiatry 23:454–459
Yuan Y, Ye Q, Chen Y, Zhang S, Li H, Lu R, Mei G, Li Y et al (2007) Plasma homocysteine level and MTHFR gene polymorphism in old age depression and mild Alzheimer’s disease. Chin J Geriatr 26:767–769
Zhang X (2007) Relationship of Hcy and its related enzyme gene polymorphisms with Alzheimer’s disease. Chin Med Sci J 20:1–28
Styczynska M, Strosznajder JB, Religa D, Chodakowska-Zebrowska M, Pfeffer A, Gabryelewicz T, Czapsk GA, Kobrys M et al (2008) Association between genetic and environmental factors and the risk of Alzheimer’s disease. Folia Neuropathol 46:249–254
Zhang J, Dai Q, Lu W, Meng F (2008) Seruam homocysteine level and MTHFR gene polymorphism and Alzheimer’s disease (AD) risk. Chin J Postgrad Med 31:40–42
Bi XH, Zhao HL, Zhang ZX, Zhan JW (2009) Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer’s disease. Neurobiol Aging 30:1601–1607
Giedraitis V, Kilander L, Degerman-Gunnarsson M, Sundelof J, Axelsson T, Syvanen AC, Lannfelt L, Glaser A (2009) Genetic analysis of Alzheimer’s disease in the Uppsala longitudinal study of adult men. Dement. Geriatr Cogn Disord 27:59–68
Li K, Liu S, Yao S, Wang B, Dai D, Yao L (2009) Interaction between interleukin-8 and methylenetetrahydrofolate reductase genes modulates Alzheimer’s disease risk. Dement. Geriatr Cogn Disord 27:286–291
Ferlazzo N, Gorgone G, Caccamo D, Curro M, Condello S, Pisani F, Ernieri F, Rossini PM et al (2011) The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline. Neuromolecular Med 13:167–174
Coppede F, Tannorella P, Pezzini I, Migheli F, Ricci G, Caldarazzo lenco E, Piaceri I, Polin A et al (2012) Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer’s disease patients and healthy controls. Antioxid Redox Signal 17:195–204
Deng X, Wang Y (2012) Association between methylenetetrahydrofolate reductase C677T and methionine synthase A2756G gene polymorphisms, Hcy plasma levels and Alzheimer’s disease. Shi Yong Yi Xue 28:3545–3548
Mansoori N, Tripathi M, Luthra K, Alam R, Lakshmy R, Sharma S, Arulselvi S, Parveen S et al (2012) MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer’s and vascular dementia and their epistatic interaction. Neurobiol Aging 33(1003):e1001–e1008
Divyakolu S, Tejaswini Y, Thomas W, Thumoju S, Sreekanth VR, Vasavi M, OmSai VR, Nagaratna V et al (2013) Evaluation of C677T polymorphism of the methylenetetrahydrofolate reductase (MTHFR) gene in various neurological disorders. Neurol Disord 2(1):1000142
Elhawary NA, Hewedi D, Arab A, Teama S, Shaibah H, Tayeb MT, Bogari N (2013) The MTHFR 677T allele may influence the severity and biochemical risk factors of Alzheimer’s disease in an Egyptian population. Dis Markers 35:439–446
Chhillar N, Singh NK, Banerjee BD, Bala K, Basu M, Sharma D (2014) Intergenotypic variation of vitamin B12 and folate in AD: in North Indian population. Ann Indian Acad Neurol 17(3):308–312
Mansouri L, Fekih-Mrissa N, Klai S, Mansour M, Gritli N, Mrissa R (2013) Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer’s disease. Clin Neurol Neurosurg 115:1693–1696
Kronenberg G, Colla M, Endres M (2009) Folic acid, neurodegenerative and neuropsychiatric disease. Curr Mol Med 9:315–323
Yoo JH, Choi GD, Kang SS (2000) Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol 20:1921–1925
Castro R, Rivera I, Blom HJ, Jakobs C, Tavares de Almeida I (2006) Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 29:3–20
Sachdev PS (2005) Homocysteine and brain atrophy. Pro Neuropsychopharmacology Biol Psychiatry 29:1152–1161
Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J et al (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci 22:1752–1762
Mattson MP, Shea TB (2003) Folate and homocysteien metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137–146
Zhang MY, Miao L, Li YS, Hu GY (2010) Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to Alzheimer’s disease. Neurosci Res 68:142–150
Hasegawa T, Ukai W, Jo DG, Xu X, Mattson MP, Nakagawa M, Araki W, Saito T et al (2005) Homocysteic acid induces intraneuronal accumulation of neurotoxic Abeta42: implications for the pathogenesis of Alzheimer’s disease. J Neurosci Res 80:869–876
Ji C, Kaplowitz N (2004) Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol 10:1699–1708
Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, Sengupta S (2006) Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 5:1
Del Bo R, Angeretti N, Lucca E, De Simoni MG, Forloni G (1995) Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett 188:70–74
Stuhlinger MC, Oka RK, Graf EE, Schmolzer I, Upson BM, Kapoor O, Szuba A, Malinow MR et al (2003) Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylar. Circulation 108:933–938
Kartal ON, Taha S, Azzi A (2005) Homocysteine induces DNA synthesis and proliferation of vascular smooth muscle cells by interfering with MAPK kinase pathway. Biofactors 24:193–199
Midorikawa S, Sanada H, Hashimoto S, Watanabe T (2000) Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem Biophys Res Commun 272:182–185
Munafo MR, Flint J (2004) Meta-analysis of genetic association studies. Trends Genet 20:439–444
Rai V, Yadav U, Kumar P, Yadav SK, Mishra OP (2014) Maternal methylenetetrahydrofolate reductase C677T polymorphism and down syndrome risk: a meta-analysis from 34 studies. PLoS ONE 9:e108552
Wang W, Wang Y, Gong F, Zhu W, Fu S (2013) MTHFR C677T polymorphism and risk of congenital heart defects: evidence from 29 case-control and TDT studies. PLoS ONE 8:e58041
Hu CY, Qian ZZ, Gong FF, Lu SS, Feng F, Wu YL, et al. (2014) Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis. J Neural Transm. 2014; [Ahead of print DOI: 10.1007/s00702-014-1261-8].
Peerbooms OL, van Os J, Drukker M, Kenis G, Hoogveld L, de Hert M et al (2011) Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun 25:1530–1543
Wu YL, Ding XX, Sun YH, Yang HY, Chen J, Zhao X, Jiang YH, Lv XL et al (2013) Association between MTHFR C677T polymorphism and depression: an updated meta-analysis of 26 studies. Prog Neuro-Psychopharmacol Biol Psychiatry 46:78–85
Rai V (2014) The methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk in Asian populations. Asian Pac J Cancer Prev 15:5853–5860
Acknowledgments
The authoress is highly grateful to Leon Bax (Chief Scientific Officer at BiostatXL, UMC Utrecht) for his valuable suggestions, which help me in statistical analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rai, V. Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis. Mol Neurobiol 54, 1173–1186 (2017). https://doi.org/10.1007/s12035-016-9722-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-016-9722-8